Glucagon-like peptide-1 receptor agonists (also known as GLP-1 receptor agonists, GLP-1 analogs, GLP1As, and incretin mimetics) are a popular group of medications used in the treatment of type 2 diabetes (T2DM) and obesity. This evidence concerns the gene GCG and type 2 diabetes mellitus.